CELL THERAPEUTICS INC
10-Q, EX-27.1, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: CELL THERAPEUTICS INC, 10-Q, 2000-08-14
Next: ROTTLUND CO INC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM JUNE 30,
2000 FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                      11,815,671
<SECURITIES>                                29,902,862
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            42,546,619
<PP&E>                                      16,636,830
<DEPRECIATION>                              12,395,847
<TOTAL-ASSETS>                              77,682,462
<CURRENT-LIABILITIES>                        8,191,958
<BONDS>                                              0
                                0
                                  2,748,764
<COMMON>                                   235,737,944
<OTHER-SE>                               (181,233,637)
<TOTAL-LIABILITY-AND-EQUITY>                77,682,462
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                               23,369,645
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             369,086
<INCOME-PRETAX>                           (22,776,705)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (22,776,705)
<EPS-BASIC>                                     (1.04)
<EPS-DILUTED>                                   (1.04)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission